Search any bill in Congress.

The bill directs the Secretary of Commerce to prepare and release an annual assessment focused on the United States' dependency on imported inputs used in fermentation-based biomanufacturing. Fermentation-based biomanufacturing involves using biological processes, such as microbes or enzymes, to produce products like pharmaceuticals, biofuels, and specialty chemicals. The report would analyze how much the U.S. relies on foreign sources for these critical inputs, identify potential risks associated with this reliance, and possibly recommend strategies to reduce vulnerabilities. This information is important because heavy dependence on imports for key biomanufacturing materials could pose risks to supply chains, national security, and economic stability, especially during global disruptions or geopolitical tensions. By regularly monitoring and reporting on this dependency, policymakers, industry stakeholders, and the public can better understand the state of the biomanufacturing supply chain and consider actions to strengthen domestic production or diversify sources. The bill does not specify enforcement or funding mechanisms but establishes transparency and awareness as foundational steps toward addressing supply chain resilience in this sector.